JOP20230169A1 - علاج انقطاع النفس أثناء النوم باستخدام cbd - Google Patents

علاج انقطاع النفس أثناء النوم باستخدام cbd

Info

Publication number
JOP20230169A1
JOP20230169A1 JOJO/P/2023/0169A JOP20230169A JOP20230169A1 JO P20230169 A1 JOP20230169 A1 JO P20230169A1 JO P20230169 A JOP20230169 A JO P20230169A JO P20230169 A1 JOP20230169 A1 JO P20230169A1
Authority
JO
Jordan
Prior art keywords
cbd
treating sleep
sleep apnea
treating
cannabidiol
Prior art date
Application number
JOJO/P/2023/0169A
Other languages
Arabic (ar)
English (en)
Inventor
Donna Gutterman
Joseph Palumbo
Terri Sebree
Original Assignee
Harmony Biosciences Man Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harmony Biosciences Man Inc filed Critical Harmony Biosciences Man Inc
Publication of JOP20230169A1 publication Critical patent/JOP20230169A1/ar

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
JOJO/P/2023/0169A 2021-01-28 2023-07-27 علاج انقطاع النفس أثناء النوم باستخدام cbd JOP20230169A1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163142835P 2021-01-28 2021-01-28
PCT/IB2022/050781 WO2022162621A1 (en) 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd

Publications (1)

Publication Number Publication Date
JOP20230169A1 true JOP20230169A1 (ar) 2023-07-27

Family

ID=80222209

Family Applications (1)

Application Number Title Priority Date Filing Date
JOJO/P/2023/0169A JOP20230169A1 (ar) 2021-01-28 2023-07-27 علاج انقطاع النفس أثناء النوم باستخدام cbd

Country Status (11)

Country Link
US (1) US20240307418A1 (https=)
EP (1) EP4284349A1 (https=)
JP (1) JP2024505212A (https=)
KR (1) KR20230137404A (https=)
CN (1) CN116829135A (https=)
AU (1) AU2022213009A1 (https=)
CA (1) CA3206508A1 (https=)
IL (1) IL304827A (https=)
JO (1) JOP20230169A1 (https=)
MX (1) MX2023008876A (https=)
WO (1) WO2022162621A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2627344A (en) * 2022-12-16 2024-08-21 Kingdom Therapeutics Ltd Cannabinoid based therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
CA2760460C (en) 2009-04-28 2019-04-02 Alltranz Inc. Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same
BR112019026877A2 (pt) * 2017-06-19 2020-06-30 Zelda Therapeutics Operations Pty Ltd composições para distúrbios do sono e tratamentos do mesmo
IL278548B2 (en) * 2018-05-11 2025-07-01 Rhodes Tech Inc Pharmaceutical preparations containing dronabinol and sprays containing the same pharmaceutical preparations
WO2019224824A1 (en) * 2018-05-24 2019-11-28 To Pharmaceuticals Llc Cannabis-based compositions for the treatment of autistic spectrum disorders
BR112022004175A2 (pt) * 2019-09-17 2022-05-31 Zynerba Pharmaceuticals Inc Tratamento de encefalopatia de syngap1

Also Published As

Publication number Publication date
EP4284349A1 (en) 2023-12-06
MX2023008876A (es) 2023-09-12
CN116829135A (zh) 2023-09-29
KR20230137404A (ko) 2023-10-04
AU2022213009A1 (en) 2023-08-17
WO2022162621A1 (en) 2022-08-04
IL304827A (en) 2023-09-01
CA3206508A1 (en) 2022-08-04
JP2024505212A (ja) 2024-02-05
US20240307418A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
JOP20210140A1 (ar) معالجة متلازمة الحذف 22q11.2 بكانابيديول
JOP20200082B1 (ar) علاج متلازمة الكروموسوم إكس الهش باستخدام الكانابيديول
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
MX380767B (es) Métodos para reducir el riesgo cardiovascular.
EA201201465A1 (ru) Лекарственные формы хинонов для лечения офтальмических заболеваний
EA201690754A1 (ru) Применение ингибитора pcsk9 для лечения гиперлипидемии
BR112013027554A2 (pt) "usos de compostos no tratamento de mal de alzheimer, doença de huntington, autismo e outros distúrbios"
UY35313A (es) Antiadhesion de leucocitos para mitigar los potenciales eventos adversos causados por los dominios de unión específicos de cd3
BR112015022197A2 (pt) tratamento de cataplexia
AR097178A1 (es) Diagnóstico y terapias anticáncer que comprenden células madre cancerosas
EA201591687A1 (ru) Индукционная терапия ритуксимабом с последующим лечением с использованием глатирамера ацетата
BR112014007357A2 (pt) métodos de monitoramento terapêutico de fármacos de varredura de nitrogênio
BR112014031806A8 (pt) método para tratamento de câncer positivo para gd2
NZ716627A (en) Methods of treating behavioral symptoms of neurological and mental disorders
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
BR112015026238A2 (pt) tratamento de câncer com dihidropirazino-pirazinas
JOP20190008A1 (ar) علاج ومنع اضطرابات النوم
EA201590933A1 (ru) Новые перорально биодоступные соединения, модулирующие контроль дыхания, и способы их использования
BR112016012840A2 (pt) Derivado de pirimidina e fonte de ácido graxo para uso no tratamento de prisão de ventre
BR112019006216A2 (pt) compostos de p2x3 e/ou p2x2/3 e métodos
JOP20230169A1 (ar) علاج انقطاع النفس أثناء النوم باستخدام cbd
MY196979A (en) Method of treating disease by auricular anesthesia of cranial nerves
BR112015007095A2 (pt) derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados
BR112015026805A2 (pt) métodos e tratamento para determinadas desordens baseadas em dismielinização e desmielinização e/ ou promoção da remielinização
UA104733U (uk) Спосіб лікування гастропатій у пацієнтів з хронічним обструктивним захворюванням легень